19 maart 2024: zie ook dit artikel: https://kanker-actueel.nl/complementaire-behandelingen-bv-acupunctuur-psychosociale-ondersteuning-massage-verminderen-pijn-47-procent-en-angst-57-procent-bij-in-ziekenhuis-opgenomen-kankerpatienten.html

19 maart 2024: Bron: 2023 Nov 1;6(11):e2342482

Uit de IMPACT studie, een gerandomiseerde studie, blijkt dat zowel acupunctuur als massage voor pijnverlichting kan zorgen bij kankerpatiënten met gevorderde kanker. Ook verbeterden beide behandelingen de vermoeidheid, slapeloosheid en daarmee dus ook de kwaliteit van leven. Primaire doel van de studie was te kijken naar het onderlinge verschil maar daar blijkt nauwelijks verschil tussen te zitten, aldus de onderzoekers. 

Zie deze 2 grafieken met als eerste grafiek hoe de deelnemers werden geselecteerd enz.:



De resultaten in grafiek:




De resultaten vertaald uit het abstract:

Resultaten:

  • Er waren in totaal 298 deelnemers ingeschreven (gemiddelde leeftijd, 58,7 [14,1] jaar, 200 [67,1%] waren vrouwen, 33 [11,1%] zwart, 220 [74,1%] blank, 46 [15,4%] Spaans en 78,5% met solide tumoren).
  • De gemiddelde (SD) score voor de ergste pijn bij baseline was 6,9 (1,5).
  • Gedurende 26 weken verminderde acupunctuur de ergste pijnscore, met een gemiddelde verandering van -2,53 (95% BI, -2,92 tot -2,15) punten, en massage verminderde de ergste pijnscore, met een gemiddelde verandering van -3,01 ( 95% BI, -3,38 tot -2,63) punten;
  • het verschil tussen de groepen was niet significant (-0,48; 95% BI, -0,98 tot 0,03; P = 0,07).
  • Beide behandelingen verbeterden ook vermoeidheid, slapeloosheid en kwaliteit van leven zonder significante verschillen tussen de groepen.
  • Bijwerkingen waren mild en omvatten blauwe plekken (6,5% van de patiënten die acupunctuur kregen) en voorbijgaande pijn (15,1% van de patiënten die massage kregen).
Conclusie:

In dit gerandomiseerde klinische onderzoek onder patiënten met gevorderde kanker werden zowel acupunctuur als massage geassocieerd met pijnvermindering en verbeterde vermoeidheid, slapeloosheid en kwaliteit van leven gedurende 26 weken; er was echter geen significant verschil tussen de behandelingen. Er is meer onderzoek nodig om te evalueren hoe deze benaderingen het beste kunnen worden geïntegreerd in de pijnbehandeling om de symptoombeheersing voor de groeiende populatie van mensen met gevorderde kanker te optimaliseren.

Het volledige studierapport is gratis in te zien of te downloaden. Hier het abstract van de studie met referentielijst en gerelateerde artikelen:

Randomized Controlled Trial
 
2023 Nov 1;6(11):e2342482.
 doi: 10.1001/jamanetworkopen.2023.42482.

Acupuncture vs Massage for Pain in Patients Living With Advanced Cancer: The IMPACT Randomized Clinical Trial

Affiliations 

Abstract

Importance: Pain is challenging for patients with advanced cancer. While recent guidelines recommend acupuncture and massage for cancer pain, their comparative effectiveness is unknown.

Objective: To compare the effects of acupuncture and massage on musculoskeletal pain among patients with advanced cancer.

Design, setting, and participants: A multicenter pragmatic randomized clinical trial was conducted at US cancer care centers consisting of a northeastern comprehensive cancer center and a southeastern cancer institute from September 19, 2019, through February 23, 2022. The principal investigator and study statisticians were blinded to treatment assignments. The duration of follow-up was 26 weeks. Intention-to-treat analyses were performed (linear mixed models). Participants included patients with advanced cancer with moderate to severe pain and clinician-estimated life expectancy of 6 months or more. Patient recruitment strategy was multipronged (eg, patient database queries, mailings, referrals, community outreach). Eligible patients had English or Spanish as their first language, were older than 18 years, and had a Karnofsky score greater than or equal to 60 (range, 0-100; higher scores indicating less functional impairment).

Interventions: Weekly acupuncture or massage for 10 weeks with monthly booster sessions up to 26 weeks.

Main outcomes and measures: The primary end point was the change in worst pain intensity score from baseline to 26 weeks. The secondary outcomes included fatigue, insomnia, and quality of life. The Brief Pain Inventory (range, 0-10; higher numbers indicate worse pain intensity or interference) was used to measure the primary outcome. The secondary outcomes included fatigue, insomnia, and quality of life.

Results: A total of 298 participants were enrolled (mean age, 58.7 [14.1] years, 200 [67.1%] were women, 33 [11.1%] Black, 220 [74.1%] White, 46 [15.4%] Hispanic, and 78.5% with solid tumors). The mean (SD) baseline worst pain score was 6.9 (1.5). During 26 weeks, acupuncture reduced the worst pain score, with a mean change of -2.53 (95% CI, -2.92 to -2.15) points, and massage reduced the Brief Pain Inventory worst pain score, with a mean change of -3.01 (95% CI, -3.38 to -2.63) points; the between-group difference was not significant (-0.48; 95% CI, -0.98 to 0.03; P = .07). Both treatments also improved fatigue, insomnia, and quality of life without significant between-group differences. Adverse events were mild and included bruising (6.5% of patients receiving acupuncture) and transient soreness (15.1% patients receiving massage).

Conclusions and relevance: In this randomized clinical trial among patients with advanced cancer, both acupuncture and massage were associated with pain reduction and improved fatigue, insomnia, and quality of life over 26 weeks; however, there was no significant different between the treatments. More research is needed to evaluate how best to integrate these approaches into pain treatment to optimize symptom management for the growing population of people living with advanced cancer.

Trial registration: ClinicalTrials.gov Identifier: NCT04095234.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Epstein reported receiving royalties from UpToDate for peer review of gastrointestinal medical oncology and palliative care topic manuscripts and honoraria for lectures to Great Debates and Updates in Gastrointestinal Malignancies. Mr Baser reported receiving grants from the Patient-Centered Outcomes Research Institute (PCORI) during the conduct of the study. Dr Deng reported receiving grants from the PCORI during the conduct of the study and outside the submitted work. Dr Farrar reported receiving grants from the PCORI during the conduct of the study; and grants from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences, the NIH National Institute of Diabetes and Digestive and Kidney Diseases, and the NIH National Institute of Neurological Disorders and Stroke; a contract from the US Food and Drug Administration; personal fees from Vertx Pharma and EicOsis Pharma outside the submitted work; and is the unpaid president of the US Association for the Study of Pain. Dr Mao reported receiving grants from Tibet CheeZheng Tibetan Medicine Co Ltd to Memorial Sloan Kettering Cancer Center and Zhongke Health International LLC to Memorial Sloan Kettering Cancer Center outside the submitted work; and serving in an unpaid leadership or fiduciary role as copresident of the Society for Acupuncture Research. No other disclosures were reported.

Figures

Figure 1.
 
Figure 2.

Similar articles

Cited by

References

    1. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070-1090.e9. doi:10.1016/j.jpainsymman.2015.12.340 - DOI PubMed
    1. Porta-Sales J, Nabal-Vicuna M, Vallano A, et al. . Have we improved pain control in cancer patients? a multicenter study of ambulatory and hospitalized cancer patients. J Palliat Med. 2015;18(11):923-932. doi:10.1089/jpm.2015.29002.jps - DOI PubMed
    1. Dong ST, Butow PN, Costa DS, Lovell MR, Agar M. Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manage. 2014;48(3):411-450. doi:10.1016/j.jpainsymman.2013.10.027 - DOI PubMed
    1. Dong ST, Butow PN, Tong A, et al. . Patients’ experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study. Support Care Cancer. 2016;24(3):1373-1386. doi:10.1007/s00520-015-2913-4 - DOI PubMed
    1. Johnsen AT, Petersen MA, Pedersen L, Groenvold M. Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med. 2009;23(6):491-501. doi:10.1177/0269216309105400 - DOI PubMed
    1. Kirkova J, Rybicki L, Walsh D, Aktas A, Davis MP, Karafa MT. The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am J Hosp Palliat Care. 2011;28(5):350-355. doi:10.1177/1049909110391464 - DOI PubMed
    1. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8(3):175-179. doi:10.1007/s005200050281 - DOI PubMed
    1. Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14(8):831-836. doi:10.1007/s00520-005-0899-z - DOI PubMed
    1. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28(3):465-470. - PubMed
    1. Paice JA, Bohlke K, Barton D, et al. . Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023;41(4):914-930. doi:10.1200/JCO.22.02198 - DOI PubMed
    1. Liou KT, Trevino KM, Meghani SH, et al. . Fear of analgesic side effects predicts preference for acupuncture: a cross-sectional study of cancer patients with pain in the USA. Support Care Cancer. 2021;29(1):427-435. doi:10.1007/s00520-020-05504-y - DOI PMC PubMed
    1. Mao JJ, Ismaila N, Bao T, et al. . Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998-4024. doi:10.1200/JCO.22.01357 - DOI PubMed
    1. Hershman DL, Unger JM, Greenlee H, et al. . Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial. JAMA. 2018;320(2):167-176. doi:10.1001/jama.2018.8907 - DOI PMC PubMed
    1. Mao JJ, Liou KT, Baser RE, et al. . Effectiveness of electroacupuncture or auricular acupuncture vs usual care for chronic musculoskeletal pain among cancer survivors: the PEACE randomized clinical trial. JAMA Oncol. 2021;7(5):720-727. doi:10.1001/jamaoncol.2021.0310 - DOI PMC PubMed
    1. He Y, Guo X, May BH, et al. . Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis. JAMA Oncol. 2020;6(2):271-278. doi:10.1001/jamaoncol.2019.5233 - DOI PMC PubMed
    1. Kutner JS, Smith MC, Corbin L, et al. . Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial. Ann Intern Med. 2008;149(6):369-379. doi:10.7326/0003-4819-149-6-200809160-00003 - DOI PMC PubMed
    1. Boyd C, Crawford C, Paat CF, Price A, Xenakis L, Zhang W; Evidence for Massage Therapy (EMT) Working Group . the impact of massage therapy on function in pain populations—a systematic review and meta-analysis of randomized controlled trials: part II, cancer pain populations. Pain Med. 2016;17(8):1553-1568. doi:10.1093/pm/pnw100 - DOI PMC PubMed
    1. Gallicchio L, Devasia TP, Tonorezos E, Mollica MA, Mariotto A. Estimation of the number of individuals living with metastatic cancer in the United States. J Natl Cancer Inst. 2022;114(11):1476-1483. doi:10.1093/jnci/djac158 - DOI PMC PubMed
    1. Marinangeli F, Ciccozzi A, Leonardis M, et al. . Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage. 2004;27(5):409-416. doi:10.1016/j.jpainsymman.2003.10.006 - DOI PubMed
    1. Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO step III opioids in the control of pain in advanced cancer: a systematic review of the literature. Palliat Med. 2012;26(4):305-312. doi:10.1177/0269216311428528 - DOI PubMed
    1. Romero SAD, Emard N, Baser RE, et al. . Acupuncture versus massage for pain in patients living with advanced cancer: a protocol for the IMPACT randomised clinical trial. BMJ Open. 2022;12(9):e058281. doi:10.1136/bmjopen-2021-058281 - DOI PMC PubMed
    1. Karnofsky performance status scale definitions rating (%) criteria. Accessed October 2, 2023. http://www.npcrc.org/files/news/karnofsky_performance_scale.pdf
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129-138. - PubMed
    1. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88(3):287-294. doi:10.1016/S0304-3959(00)00339-0 - DOI PubMed
    1. Mendoza TR, Wang XS, Cleeland CS, et al. . The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-1196. doi:10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N - DOI PubMed
    1. Savard MH, Savard J, Simard S, Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2005;14(6):429-441. doi:10.1002/pon.860 - DOI PubMed
    1. Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items. Qual Life Res. 2009;18(7):873-880. doi:10.1007/s11136-009-9496-9 - DOI PMC PubMed
    1. US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. November 27, 2017. Accessed October 11, 2023. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs...
    1. Mao JJ, Farrar JT, Armstrong K, Donahue A, Ngo J, Bowman MA. De qi: Chinese acupuncture patients’ experiences and beliefs regarding acupuncture needling sensation—an exploratory survey. Acupunct Med. 2007;25(4):158-165. doi:10.1136/aim.25.4.158 - DOI PubMed
    1. MacDonald G. Medicine Hands: Massage Therapy for People With Cancer. Simon & Schuster; 2014.
    1. Walton T. Medical Conditions and Massage Therapy: A Decision Tree Approach. Lippincott Williams & Wilkins; 2010.
    1. Liu GF, Lu K, Mogg R, Mallick M, Mehrotra DV. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? Stat Med. 2009;28(20):2509-2530. doi:10.1002/sim.3639 - DOI PubMed
    1. Mallinckrod CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Inf J. 2008;42(4):303-319. doi:10.1177/009286150804200402 - DOI
    1. Dworkin RH, Turk DC, Wyrwich KW, et al. . Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105-121. doi:10.1016/j.jpain.2007.09.005 - DOI PubMed
    1. Vickers AJ, Vertosick EA, Lewith G, et al. ; Acupuncture Trialists’ Collaboration . Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018;19(5):455-474. doi:10.1016/j.jpain.2017.11.005 - DOI PMC PubMed
    1. MacPherson H, Vertosick EA, Foster NE, et al. ; Acupuncture Trialists’ Collaboration . The persistence of the effects of acupuncture after a course of treatment: a meta-analysis of patients with chronic pain. Pain. 2017;158(5):784-793. doi:10.1097/j.pain.0000000000000747 - DOI PMC PubMed
    1. Mao JJ, Farrar JT, Bruner D, et al. . Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial. Cancer. 2014;120(23):3744-3751. doi:10.1002/cncr.28917 - DOI PMC PubMed
    1. Groninger H, Nemati D, Cates C, et al. . Massage therapy for hospitalized patients receiving palliative care: a randomized clinical trial. J Pain Symptom Manage. 2023;65(5):428-441. doi:10.1016/j.jpainsymman.2023.01.011 - DOI PubMed
    1. Hershman DL, Unger JM, Greenlee H, et al. . Comparison of acupuncture vs sham acupuncture or waiting list control in the treatment of aromatase inhibitor–related joint pain: a randomized clinical trial. JAMA Netw Open. 2022;5(11):e2241720. doi:10.1001/jamanetworkopen.2022.41720 - DOI PMC PubMed
    1. LeBlanc TW, McNeil MJ, Kamal AH, Currow DC, Abernethy AP. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol. 2015;16(7):e333-e341. doi:10.1016/S1470-2045(15)00080-7 - DOI PubMed
    1. Ramsdale E, Mohamed M, Yu V, et al. . Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment. Oncologist. 2022;27(7):e580-e588. doi:10.1093/oncolo/oyac053 - DOI PMC PubMed
    1. Yun H, Sun L, Mao JJ. Growth of integrative medicine at leading cancer centers between 2009 and 2016: a systematic analysis of NCI-designated comprehensive cancer center websites. J Natl Cancer Inst Monogr. 2017;2017(52):lgx004. doi:10.1093/jncimonographs/lgx004 - DOI PMC PubMed
    1. Desai K, Liou K, Liang K, Seluzicki C, Mao JJ. Availability of integrative medicine therapies at National Cancer Institute–designated comprehensive cancer centers and community hospitals. J Altern Complement Med. 2021;27(11):1011-1013. doi:10.1089/acm.2021.0102 - DOI PMC PubMed
    1. Liou KT, Korenstein D, Mao JJ. Medicare coverage of acupuncture for chronic low back pain: does it move the needle on the opioid crisis? J Gen Intern Med. 2021;36(2):527-529. doi:10.1007/s11606-020-05871-6 - DOI PMC PubMed

Plaats een reactie ...

Reageer op "Acupunctuur en massage zorgen voor pijnvermindering en verbeterde vermoeidheid, slapeloosheid en kwaliteit van leven. Onderling zagen de onderzoekers geen verschil."


Gerelateerde artikelen